News

Beam Therapeutics (BEAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
The KIMS Cancer Centre has successfully treated a patient suffering from Cutaneous T-cell Lymphoma using Electron Beam Therapy (EBT), a specialized radiation technique designed to precisely target ...
Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.
Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...
Beam Therapeutics Inc. research and ratings by Barron's. View BEAM revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has ...
Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The ...
The Edison Histotripsy System, which received FDA De Novo clearance in October 2023, uses non-invasive focused ultrasound ...
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...
With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...
Niels Finsen's groundbreaking work with light therapy revolutionized medical treatment, earning him the Nobel Prize in 1903.